The civic-run King Edward Memorial Hospital in Mumbai on Wednesday began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said. The hospital, located in Parel......
The global trials were halted after a study participant suffered a ‘potentially unexplained illness', reports Sohini Das. IMAGE: Serum Institute of India is the Indian partner of AstraZeneca......
The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......
Vaccine major Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly......
The coronavirus vaccine developed by Oxford University and AstraZeneca “should be” effective against the highly transmissible new strain of the virus, a United Kingdom media report said......
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......
Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......